An Update on Clinical Trials Using Cord Blood and Cord Tissue

An Update on Clinical Trials Using Cord Blood and Cord Tissue

Stem cells obtained from cord blood and cord tissue are being utilized in regenerative medicine for a varying host of conditions. The most recent research indicates promising results for the treatment of neurological disorders, immune deficiencies, perinatal brain injuries, as well as degenerative diseases, and skin abnormalities.


Read More


Age Major Factor in Stem Cell Transplantation Success

Age Major Factor in Stem Cell Transplantation Success

In HLA-matched transplants, younger donor age was the only factor reliably associated with patient survival. Other secondary selection characteristics included sex, ethnicity, the presence of cytomegalovirus and non-HLA and HLA genetic factors. Several factors are believed to inhibit the proper functioning of stem cells as the donor ages, making the young stem cells in cord blood a beneficial source when HLA-matching is equal.


Read More


Enhancing Cord Blood Banking through Advancements in Expansion Technologies

Enhancing Cord Blood Banking through Advancements in Expansion Technologies

Ex vivo expansion has the potential to greatly increase the use of cord blood stem cells as a standard treatment. A growing number of studies are looking at various methods of expanding cord blood stem cells, and a number of these studies are in the second and third phases, suggesting that ex vivo expansion protocols are proving safe, effective and feasible.


Read More


The Zika Virus Risk & Cord Blood Banking

The Zika Virus Risk & Cord Blood Banking

For everyone other than pregnant moms, the Zika virus poses only a small risk. It’s a much more serious situation for expecting moms, regardless of which trimester they are in. Zika can be passed from a pregnant woman to her fetus. When it comes to preserving cord blood during the time that people are worried  about Zika spreading, Cryo-Cell International has taken  extensive precautions to ensure safe storage of all units.

Read More


Cord Tissue Processing Key Role in Regenerative Medicine

Cord Tissue Processing Key Role in Regenerative Medicine

Stem cells derived from cord tissue are increasingly being utilized in regenerative medicine for a wide range of conditions. The latest research points to the critical importance of storing the cord tissue pieces rather than enzymatic digestion before cryopreservation to maximize the likelihood of use.

Read More


Cord Blood for Brain Injury: A Synopsis of the Latest Research

Cord Blood for Brain Injury: A Synopsis of the Latest Research

As it stands now, available treatments for neurological injuries are limited in scope. Most therapies are aimed at managing the symptoms of the conditions rather than the underlying causes. There is tremendous interest—and strides being made—in developing stem cell therapies as potential treatments. The use of umbilical cord blood as a source of stem cells for such therapies represents a potential sea change in treatments and results.
 

Read More


Stem Cells Making a Difference in Treating MS

Stem Cells Making a Difference in Treating MS

Results from a three year trial involving a combination of high-dose immunosuppressive therapy (HDIT) followed by an autologous stem cell transplant show incredible promise in the treatment of this debilitating disease.
 

Read More


Advances in Cord Blood Expansion and Homing Technologies Enhance the Value of Cord Blood Banking

Advances in Cord Blood Expansion and Homing Technologies Enhance the Value of Cord Blood Banking

The most exciting advance in cord blood banking research is the recent discovery of a molecule, UM171, which can dramatically increase the number of stem cells in a cord blood unit. A phase I study is scheduled for December 2014.


Read More


Cryo-Cell Is Awarded Cord Blood Banking Industry’s Most Prestigious Quality Accreditation

Cryo-Cell Is Awarded Cord Blood Banking Industry’s Most Prestigious Quality Accreditation

Cryo-Cell International is the first private cord blood bank in the U.S. to receive The Foundation for the Accreditation for Cellular Therapy (FACT) accreditation for voluntarily adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization.
 

Read More


Adopting a New Cord Blood Processing Technology

Adopting a New Cord Blood Processing Technology

This November, Cryo-Cell is embracing a processing technology that results in a superior stem cell sample by:
  1. Depleting more harmful red blood cells
  2. Retaining more desirable stem cells
Red blood cell contamination has been shown to cause serious complications in transplant patients, including renal failure and hemolytic transfusion reactions.
 

Read More